Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Antihypertensive drug does not lower death risk in HFrEF patients
Use of an antihypertensive drug does not appear to reduce the risk of all-cause mortality or hospital readmission in hospitalized older patients with heart failure with reduced ejection fraction (HFrEF) who are receiving contemporary treatments for HF, reveals a recent study.
Antihypertensive drug does not lower death risk in HFrEF patients
08 Jun 2022
Microwave ablation: a better treatment alternative for NSCLC?
In patients with non-small-cell lung cancer (NSCLC), image-guided thermal ablation (IGTA) via microwave ablation (MWA) appears to deliver better survival benefit compared with another IGTA subtype, radiofrequency ablation (RFA), or stereotactic body radiation therapy (SBRT), according to a systematic review and meta-analysis presented at ATS 2022.
Microwave ablation: a better treatment alternative for NSCLC?
08 Jun 2022
Hodgkin lymphoma incidence rising in Asia, HK tops global rise in males
The incidence of Hodgkin lymphoma has increased in the past decade, especially in Asian countries, females, and the younger population, a global study has shown.
Hodgkin lymphoma incidence rising in Asia, HK tops global rise in males
08 Jun 2022
Long-term steroid OK for RA but challenges guidelines
Contrary to what current guidelines advocate, long-term use of corticosteroid works fine in older patients with rheumatoid arthritis (RA), suggests the much-anticipated GLORIA* trial presented at EULAR 2022.
Long-term steroid OK for RA but challenges guidelines
08 Jun 2022
Weight loss intervention may improve COPD symptoms
In addition to cardiometabolic benefits, a lifestyle intervention aimed at weight loss in patients with chronic obstructive pulmonary disease (COPD) who are overweight or obese may reduce COPD symptoms, according to results of the INSIGHT COPD trial presented at ATS 2022.